Joseph P. Lyssikatos serves as Executive at Enliven Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joseph P. Lyssikatos has executed 52 insider transactions totaling $5.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 6, 2026 involved selling 5,000 shares valued at $145.2K.
Joseph P. Lyssikatos currently holds 740,188 shares of Enliven Therapeutics, Inc. (ELVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph P. Lyssikatos has been a net seller of ELVN stock. They have purchased $0 and sold $5.0M worth of shares.
Joseph P. Lyssikatos's most recent insider trade was on Feb 6, 2026, when they sold 5,000 shares at $29.04 per share.
Get notified when new Form 4 filings are submitted
| $16.84 |
| Discretionary |
| Nov 19, 2025 | ELVN | $11.4K | Sale | 492 | $23.09 | Discretionary |
| Nov 19, 2025 | ELVN | $267.8K | Sale | 12,008 | $22.30 | Discretionary |
| Oct 20, 2025 | ELVN | $276.0K | Sale | 12,500 | $22.08 | Discretionary |
| Sep 26, 2025 | ELVN | $81.0K | Sale | 4,000 | $20.25 | Discretionary |
| Sep 23, 2025 | ELVN | $30.0K | Sale | 1,500 | $20.03 | Discretionary |
| Sep 19, 2025 | ELVN | $42.6K | Sale | 2,130 | $20.02 | Discretionary |
| Sep 19, 2025 | ELVN | $93.1K | Sale | 4,870 | $19.11 | Discretionary |
| Aug 21, 2025 | ELVN | $150.1K | Sale | 7,500 | $20.01 | Discretionary |
| Aug 19, 2025 | ELVN | $98.1K | Sale | 5,000 | $19.62 | Discretionary |
| Jul 21, 2025 | ELVN | $13.2K | Sale | 576 | $22.90 | Discretionary |
| Jul 21, 2025 | ELVN | $265.4K | Sale | 11,924 | $22.26 | Discretionary |
| Aug 29, 2024 | ELVN | $1.2K | Sale | 50 | $23.08 | Planned |
| Aug 29, 2024 | ELVN | $268.6K | Sale | 11,950 | $22.48 | Planned |
| Jul 31, 2024 | ELVN | $85.4K | Sale | 3,099 | $27.56 | Planned |
| Jul 29, 2024 | ELVN | $5.6K | Sale | 203 | $27.43 | Planned |
| Jul 29, 2024 | ELVN | $314.9K | Sale | 11,797 | $26.69 | Planned |
| Jul 1, 2024 | ELVN | $274.7K | Sale | 12,000 | $22.89 | Planned |
| May 29, 2024 | ELVN | $47.8K | Sale | 2,123 | $22.52 | Planned |
| May 29, 2024 | ELVN | $13.4K | Option Exercise | 12,000 | $1.12 | Planned |
| May 29, 2024 | ELVN | $212.9K | Sale | 9,877 | $21.56 | Planned |
| Apr 29, 2024 | ELVN | $196.2K | Sale | 10,987 | $17.86 | Planned |
| Apr 29, 2024 | ELVN | $18.7K | Sale | 1,013 | $18.48 | Planned |
| Apr 29, 2024 | ELVN | $13.4K | Option Exercise | 12,000 | $1.12 | Planned |
| Apr 11, 2024 | ELVN | $33.6K | Option Exercise | 30,000 | $1.12 | Planned |
| Apr 11, 2024 | ELVN | $751.2K | Sale | 30,000 | $25.04 | Planned |
| Apr 1, 2024 | ELVN | $13.4K | Option Exercise | 12,000 | $1.12 | Planned |
| Apr 1, 2024 | ELVN | $41.7K | Sale | 2,352 | $17.72 | Planned |
| Apr 1, 2024 | ELVN | $180.0K | Sale | 9,577 | $18.80 | Planned |